Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-11-18
1994-09-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546155, A61K 3147, C07D21548
Patent
active
053489624
ABSTRACT:
This present invention relates to a class of 4-hydroxy-2-(1H)-quinolones which are substituted in the 3-position by an optionally substituted aryl substituent. These compounds are selective non-competitive antagonists of N-methyl-D-aspartate (NMDA) receptors.
REFERENCES:
Helv. Chim. Acta., 1951, vol. 34, pp. 1050-1060 (English Translation).
Z. Naturforsch., 1982, 37b, pp. 1196-1200 (English Translation).
Monatsch. Chem. 1967, vol. 98, pp. 1-8 (English Translation).
Monatsch. Chem. 1969, vol. 100, pp. 951-958 (English Translation).
Monatsch. Chem. 1985, vol. 116, pp. 1005-1015 (English Translation).
Yakugaku zasshi, 1970, vol. 90, pp. 818-828 (English Translation).
British Journal of Pharmacology, Proc. Suppl. Jul. 10-12 (1991), by S. Grimwood, et al.
Proc. Natl. Acad. Sci. USA, vol. 83, pp. 7104-7108, Sep. 1986 Wong et al.
Dickensen and Aydar, Neuroscience Lett. 1991; 121, 263.
Murray, et al Pain, 1991, 44, 179.
Woolf and Thompson, Pain, 1991 44 293.
Trullas and Skolnick, Eur. J. Pharmacol 1990, 185 1.
Kehne, et al Eur. J. Pharmacol., 1991, 193 283.
Werling, et al J. Pharmacol. Exp. Ther, 1990, 255 40.
Marrazzi, et al Life Sciences, 1990 47 PL-41.
Turski, et al Nature (London), Jan. 31, 1991.
Lauritzen, et al, Journ. Of Cerebral Blood Flow and Metabolism 1991, vol. 11, suppl. 2, Abstract XV-4.
Bagetta, et al Br. J. Pharmacol., 1990, 101 776.
Lipton, et al Society for Neuro. Abstr. 1990, 16, 128.11.
van den Pol. et al, science, 1990, 250, 1726.
Urbanski, Endocrinology, 1990, 172 2223.
J. Neurochem., 1985, 45 477.
Neurochem. Int. 1983, 5 479.
Life. Sci., 1981, 28, 1597.
J. Heterocycl. Chem., 1984, 21 737.
Bull. Chem. Soc. Jpn. 1980, 5-1057.
J. Heterocycl. Chem. 1989, 26 281.
J. Heterocycl. Chem., 1975, 12, 351.
J. Heterocycl. chem., 1988, 25, 857.
Journal of Cerebral Blood Flow and metabolism, vol. 11, Suppl. 2, 1991, pp. S222, by M. Lauritzen, et al.
Kulagowski Janusz J.
Leeson Paul D.
Mawer Ian M.
Rowley Michael
Davis Zinna N.
Ivy C. Warren
Merck Sharpe & Dohme Ltd.
North Robert J.
Winokur Melvin
LandOfFree
Hydroxyquinolone derivatives compounds which have pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxyquinolone derivatives compounds which have pharmaceutical, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyquinolone derivatives compounds which have pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2429891